IV 
110TH CONGRESS 
1ST SESSION 
H. RES. 248 
Honoring the contributions of patient participants in clinical trials. 
IN THE HOUSE OF REPRESENTATIVES 
MARCH 15, 2007 
Mr. BOUCHER (for himself and Mr. CANNON) submitted the following 
resolution; which was referred to the Committee on Energy and Commerce 
RESOLUTION 
Honoring the contributions of patient participants in clinical 
trials. 
Whereas clinical trials of new medicines and vaccines are vital 
to advancing science and conquering disease; 
Whereas a clinical trial is a scientific test of the effectiveness 
and safety of a new medicine or vaccine with the consent 
of human volunteers, providing invaluable information to 
medical researchers and physicians; 
Whereas over 2,300,000 people enable medical advances by 
actively participating in nearly 80,000 clinical trials every 
year in the United States; 
Whereas participants join clinical trials in order to help find 
better ways to prevent, detect, diagnose, or treat illnesses 
and to improve medicines; 
VerDate Aug 31 2005 
00:50 Mar 16, 2007
Jkt 059200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6300
E:\BILLS\HR248.IH
HR248
mstockstill on PROD1PC66 with BILLS
•HRES 248 IH 
Whereas every patient using a medicine greatly benefits from 
essential knowledge of safety and effectiveness possible 
only through the contribution of clinical trial volunteers; 
Whereas clinical trial volunteers are credited with helping to 
develop the treatments that have cut the death rate of 
heart disease by 50 percent; 
Whereas 20 percent of all participants in trials of new medi-
cines are over the age of 65, creating invaluable knowl-
edge about the unique needs of seniors; 
Whereas over 60 percent of children with cancer are enrolled 
in clinical trials, offering hope to children and their fami-
lies across America; 
Whereas 41 percent of eligible AIDS patients participate in 
cooperative studies, enabling continued progress in the ef-
fort to defeat this disease; 
Whereas 80 percent of all eligible lung cancer patients are 
enrolled in a clinical trial, allowing new generations of 
medicines to advance against a disease that has not pre-
viously had effective treatments; 
Whereas the contributions of clinical trial participants have 
led to the discovery of new treatments and cures and an 
improved quality of life for all; and 
Whereas clinical trial volunteers are needed now more than 
ever to enable advances against conditions like Alz-
heimer’s, which will exact an incalculable human and eco-
nomic cost as baby boomers become seniors unless effec-
tive and safe new treatments are developed: Now, there-
fore, be it 
Resolved, That the House of Representatives— 
VerDate Aug 31 2005 
00:50 Mar 16, 2007
Jkt 059200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\HR248.IH
HR248
mstockstill on PROD1PC66 with BILLS
•HRES 248 IH 
(1) honors and recognizes the sacrifice, commit-
ment, and contributions of clinical trial participants; 
and 
(2) encourages everyone to learn about the im-
portance of clinical trials and the important role of 
trial participants. 
Æ 
VerDate Aug 31 2005 
00:50 Mar 16, 2007
Jkt 059200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6301
E:\BILLS\HR248.IH
HR248
mstockstill on PROD1PC66 with BILLS